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RNA cis elementsme cyclization is mediated by two pairs of long-distance RNA/RNA interactions:
the 5′CS/3′CSI (conserved sequence) and the 5′UAR/3′UAR (upstream AUG region) base pairings. Antisense
peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs), designed to interfere with the 5′
CS/3′CSI or 5′UAR/3′UAR base pairings, were previously shown to inhibit WNV. In this study, we selected and
characterized WNVs resistant to a PPMO targeting the 3′UAR (3′UAR-PPMO). All resistant viruses
accumulated one-nucleotide mutations within the 3′UAR, leading to a single-nucleotide mismatch or a
weakened base-pairing interaction with the 3′UAR-PPMO. Remarkably, a one-nucleotide mutation within the
5′UAR was correspondingly co-selected; the 5′UAR mutation restored the base pairing with the 3′UAR
mutation. Mutagenesis of WNV demonstrated that the single-nucleotide change within the 3′UAR-PPMO-
target site conferred the resistance. RNA binding analysis indicated that the single-nucleotide change
reduced the ability of 3′UAR-PPMO to block the RNA/RNA interaction required for genome cyclization. The
results suggest a mechanism by which WNV develops resistance to 3′UAR-PPMO, through co-selection of the
5′UAR and 3′UAR, to create a mismatch or a weakened base-pairing interaction with the PPMO, while
maintaining the 5′UAR/3′UAR base pairings.
© 2008 Elsevier Inc. All rights reserved.Introduction
Many ﬂaviviruses are emerging or reemerging pathogens, includ-
ing the four serotypes of dengue virus (DENV), West Nile virus (WNV),
yellow fever virus (YFV), Japanese encephalitis virus (JEV), and tick-
borne encephalitis virus (TBEV). DENV alone infects 50 to 100 million
humans each year (Gubler et al., 2007). Since the initial outbreak of
WNV in New York in 1999, the virus has caused thousands of human
cases each year, and has spread throughout North America (Kramer
et al., 2007). There is no approved antiviral therapy for treatment of
ﬂavivirus infections. Human vaccines for ﬂavivirus infections are
currently available only for YFV, JEV, and TBEV. Vaccines for WNV are
approved only for equine use (Davis et al., 2001; Minke et al., 2004; Ng
et al., 2003). Development of a vaccine for DENV has been challenging,
primarily because of the need to simultaneously immunize against all
four DENV serotypes. The large disease burden caused by ﬂaviviruses
makes the development of effective therapies of acute importance to
global public health.
The ﬂavivirus genome is a single-strand, plus-sense RNA of
approximately 11,000 nucleotides (nt). It consists of a 5′ untranslatedolis Road, #05-01 Chromos,
).
l rights reserved.region (UTR), a long open reading frame (ORF), and a 3′ UTR
(Lindenbach et al., 2007). The single ORF encodes a polyprotein,
which is processed by viral and cellular proteases into 10 mature
proteins. Three structural proteins (capsid, premembrane or mem-
brane, and envelope) are required for viral particle formation. Seven
nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5)
are involved in viral RNA replication (Lindenbach et al., 2007);
additionally, the nonstructural proteins play roles in virion assembly
(Kummerer and Rice, 2002; Leung et al., 2008; Liu et al., 2003; Patkar
and Kuhn, 2008) and evasion of host innate immune responses (Best
et al., 2005; Guo et al., 2005; Liu et al., 2005; Munoz-Jordan et al.,
2003, 2005).
Flavivirus genome cyclization is essential for viral replication. As
shown in Fig. 1A usingWNV genome as an example, two pairs of long-
distance RNA/RNA interactions contribute to the genome cyclization
for mosquito-borne ﬂaviviruses. One RNA interaction involves base
pairings between a 5′ conserved sequence (5′CS; located in the
N-terminal coding region of the C gene) and a 3′CSI (located in the 3′
UTR) (Hahn et al., 1987). The 5′CS/3′CSI interaction is important for
efﬁcient RNA-dependent RNA polymerase (RdRp) activity (Filomatori
et al., 2006; You and Padmanabhan, 1999), and for viral replication
(Bredenbeek et al., 2003; Corver et al., 2003; Khromykh et al., 2001;
Koﬂer et al., 2006; Lo et al., 2003; Men et al., 1996). A second long-
range RNA/RNA interaction involves base pairings between a 5′UAR
Fig. 1. Selection of 3′UAR-PPMO resistant viruses. (A) Terminal secondary structures and potential long-distance RNA interactions of WNV genome. Stem–loop structures were
calculated by the Mfold program (Mathews et al., 1999), and were veriﬁed by RNA structure probing (Dong et al., in press). The two long-distance RNA interactions, 5′CS/3′CSI and
5′UAR/3′UAR, are indicated by dashed lines. The sequences for the 5′UAR, 5′CS, 3′CSI, and 3′UAR are labeled. The viral sequence is taken from GenBank accession no. AF404756. The
AUG initiation codon of the open reading frame is circled. The nucleotides are numbered for both ends; “-” denotes numbering from the 3′ end of the genome. The nucleotides that are
targeted by the 3′UAR-PPMO are shaded in grey. (B) The 5′UAR/3′UAR and 5′CS/3′CSI base-pairing interactions that contribute to the cyclization of WNV genomic RNA. (C) Antisense
PPMO targeting 3′UAR of WNV RNA (3′UAR-PPMO). P007 represents an Arg-rich peptide that is conjugated to the 5′ end of the PMO to facilitate cellular uptake. The composition of
P007 and structure of the PPMO backbonewere described previously (Deas et al., 2005). (D) Selection scheme for 3′UAR-PPMO-resistant virus. Drug concentrations for each selection
passage (P1 to P8) are indicated. (E) Resistance phenotype of viruses during selection. Vero cells were infected with the indicated viruses at an MOI of 0.1. After incubation of the
infected cells with or without 3′UAR-PPMO for 42 h, viral titers in culture ﬂuids were determined using plaque assays. Three independent selections were performed (Sel I, II, and III).
Mean results from P2, P7, and P8 are presented for each selection. Error bars represent standard deviations from three experiments.
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3′ terminal stem–loop of the genomic RNA). The 5′UAR/3′UAR
interaction plays a critical role in DENV-2 (Alvarez et al., 2005b,
2008;) and WNV (Zhang et al., 2008) replication.
Phosphorodiamidate morpholino oligomers (PMOs) are uncharged,
water-soluble, nuclease-resistant antisense agents that contain purine
and pyrimidine bases attached to a backbone composed of morpholine
rings joined by phosphorodiamidate intersubunit linkages (Summer-
ton and Weller, 1997). An Arg-rich peptide was conjugated to the 5′
terminus of the PMO, creating peptide-conjugated PMO (PPMO), to
facilitate cellular uptake of the oligomers (Deas et al., 2005). Using
WNV, we previously showed that antisense PPMOs, with sequences
designed to block the base pairings of 5′CSI/3′CSI or the 5′UAR/3′UAR,
are potent inhibitors of WNV replication in cell culture (Deas et al.,
2005; Zhang et al., 2008). Furthermore, a PPMO targeting the 3′CSI
region was able to partially protect WNV-infected mice from viral
disease (Deas et al., 2007). Similar antiviral activities of PPMOs targeting
the 5′CSI/3′CSI interaction were reported for DENV in cell culture and
mouse (Holden et al., 2006; Kinneyet al., 2005; Stein et al., 2008). These
results suggest that antisense PPMOs could be developed for antiviral
therapy.
Here we select and characterize WNV that are resistant to a PPMO
targeting the 3′UAR. The results show that WNV develops resistance
to the 3′UAR-PPMO through accumulation of a single-nucleotide
changewithin the 3′UAR sequence, resulting in a nucleotidemismatchor a weakened base-pairing interaction with the 3′UAR-PPMO.
Interestingly, a single-nucleotide substitution within the 5′UAR was
co-selected in the resistant viruses, leading to the restoration of
perfect base pairing between the mutated 5′UAR and the mutated 3′
UAR. Biochemical analysis showed that the single-nucleotide mis-
match reduced the ability of the PPMO to interfere with the 5′UAR/3′
UAR base pairing.
Results
Selection of 3′UAR-PPMO-resistant WNV
Fig. 1A shows the 5′ and 3′ stem–loop structures formed by the
WNV genomic RNA, and the potential base pairings of 5′CS/3′CSI and
5′UAR/3′UAR, which cyclize the genomic RNA (Fig. 1B). We previously
synthesized two PPMOs, to study the function of the 5′UAR/3′UAR
interaction: one PPMO targeted the 5′UAR, and another PPMO
targeted the 3′UAR. Viral titer reduction assay showed that the 3′
UAR-PPMO was more potent than the 5′UAR-PPMO (Zhang et al.,
2008). Therefore, we chose the 3′UAR-PPMO (Fig. 1C) for use in a
resistance study. Resistant viruses were selected by culturing WNV in
the presence of increasing concentrations of 3′UAR-PPMO (Fig. 1D).
The highest concentration of selection was set at 20 μM, because
higher concentrations of PPMOwere previously shown to be cytotoxic
(Zhang et al., 2008).
Fig. 2. Plaque morphology and sequence analysis of the 3′UAR-PPMO-resistant WNVs. (A) Plaque morphology. Plaques are presented for WT and P8 viruses for Sel I, Sel II, and Sel III.
(B) Scheme for RACE method. RNAs extracted from virions were treated with tobacco acid pyrophosphatase (TAP) to remove 5′ α- and β-phosphates, ligated intra- or inter-
molecularly using T4 RNA ligase, and RT-PCR-ampliﬁed using primers annealing to the 5′ and 3′ terminal regions of the genomic RNA. Sequencing of the RT-PCR products allowed us
to identify mutations in both ends of the viral RNA. (C) Mutations recovered from resistant viruses. Mutated nucleotides are shaded in circles. Two identical nucleotide changes (A89G
in 5′UAR and U-74C in 3′UAR; symbol “-” denotes nucleotide numbering from the 3′ end of viral genome) were recovered for Sel I and Sel III resistance viruses. One-nucleotide change
(C-69U in 3′UAR) was recovered for Sel II resistant virus.
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examine the reproducibility of the resistance results (Fig. 1E). For each
drug concentration, both the WT and selected viruses were tested for
their sensitivities to PPMO inhibition. For example, at passage 2 (P2),
the WT and three selected viruses were almost equally inhibited by
10-μM 3′UAR-PPMO (Fig. 1E, top panel). In contrast, at P7 (20-μM 3′
UAR-PPMO), the titer of the WT virus was suppressed by N105-fold,
whereas titers of the selected viruses were reduced by b104-fold
(middle panel). Further selection at 20-μM 3′UAR-PPMO (P8) did not
enhance viral resistance (bottom panel). Therefore, we terminated the
selection at P8. Among the three selections, viruses from Sel I and III
were more resistant than the virus from Sel II (Fig. 1E). The results
suggest that WNV resistant to 3′UAR-PPMO can be developed in cell
culture, although the selected viruses did not exhibit complete
resistance to the inhibitor. In the absence of PPMO, the WT and
three selected resistant viruses grew to similar titers during each
passage (Fig. 1E). Plaques from the WT, Sel I, and Sel III viruses (P8)
were similar, but were larger than those from the Sel II (P8) virus (Fig.
2A). These results indicate that the resistant viruses are not
substantially compromised in their replication ﬁtness.
Mutations in 3′UAR-PPMO-resistant viruses
Using the RACE method depicted in Fig. 2B, we sequenced the 5′
684 nt and the 3′ 528 nt of the genomic RNA, derived from the P8
resistant viruses. Extracted virion RNAs were treated with tobacco
acid pyrophosphatase (TAP) to remove 5′ α- and β-phosphates,
ligated intra- or inter-molecularly using T4 RNA ligase, and RT-PCR-
ampliﬁed using primers annealing to the 5′ and 3′ terminal regions of
the genomic RNA. Sequencing of the RT-PCR products allowed
identiﬁcation of mutations accumulated in both ends of the viral
RNA. For Sel I and Sel III viruses, identical nucleotide changes were
recovered in both the 5′UAR and the 3′UAR. A nucleotide U at position-4 (“-” denotes nucleotide numbering from the 3′ end of viral
genome), located in the 3′UAR, was mutated to C (U-74C); the U-74C
mutation resulted in a single-nucleotide mismatch with the PPMO.
Additionally, a nucleotide A at position 89, located in the 5′UAR, was
changed to G (A89G); remarkably, the A89G in 5′UAR restored the
base pairing with the U-74C in the 3′UAR (Fig. 2C). These results
suggest that WNV develop escape mutants through creation of a
single-nucleotide mismatch with the antisense PPMO, while main-
taining a perfect base pairing of the 5′UAR/3′UAR interaction.
For Sel II virus, a nucleotide C at position -69, in the 3′UAR, was
mutated to U (C-69U). The mutated C-69U could still base pair with
nucleotide G at position 83 in the 5′UAR, as well as to pair with the
corresponding G residue within the PPMO. However, the bases,
involved in the G/U base pairing between the PPMO and the 3′UAR,
are derived from a morpholine chain and an RNA chain, respectively;
whereas the bases, involved in the G/U base pairing between the 5′
UAR and the 3′UAR, are both derived from RNA chains. It is likely that
the G/U base pairing from the PPMO/RNA duplex is weaker than the G/
U base pairing from the RNA/RNA duplex, leading to the decreased
efﬁcacy of the PPMO against the Sel II virus. However, experiments are
needed to verify this possibility.
Chronological order of mutation emergence
To examine the chronological order of mutation accumulation, we
sequenced both ends of the viral RNAs, extracted from P0 to P6 viruses
of Sel I and Sel II. Because the P8 viruses from Sel I and III exhibited
identical mutations (Fig. 2C), Sel III viruses were not included in the
analysis. For Sel I (Fig. 3A), C-69U and U-74C simultaneously appeared
as mixed populations from P3 to P5. Since the sequences were derived
by consensus sequencing, designed to deﬁne the most common
sequence present at a speciﬁc locationwithin a population, we are not
able to conclude whether the C-69U and U-74C mutations were
Fig. 3. Chronology of mutation emergence during development of resistance. Representative sequencing chromatograms are presented for P0 to P8 viruses for Sel I (A), and for P0 to
P4 viruses for Sel II (B). The 5′UAR/3′UAR base pairings are depicted; mutated nucleotides are indicated in shaded circles.
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Fig. 4. Analysis of mutations responsible for 3′UAR-PPMO resistance. The plaque morphologies, 5′UAR/3′UAR base pairings, and 3′UAR-PPMO resistance are shown for WT WNV (A),
four recombinant viruses (B–E), and Sel I P8 virus (F). For resistance analysis, Vero cells were infected with the indicated virus at an MOI of 0.1 with or without 20 μMof 3′UAR-PPMO.
Viral titers in culture ﬂuids were measured by plaque assays at indicated time points post-infection. Mean values from three independent experiments are presented. Error bars
represent standard deviations.
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P6 onward, the U-74C mutation dominated, whereas the C-69U
mutation reverted to the WT sequence. Furthermore, at P8, the A89G
mutation appeared in the 5′UAR.
For Sel II (Fig. 3B), a C-69U mutation appeared at P3 as a mixed
population. The C-69Umutation dominated from P4 onward. No othermutations were identiﬁed from any later passages of Sel II (data not
shown). Overall, the results suggest that resistant WNVs arose
through a single-nucleotide mismatch (Sel I and Sel III) or a weakened
nucleotide base pairing (Sel II) between the 3′UAR and the PPMO;
when the 3′UARmutation resulted in a mismatched base pairing with
the 5′UAR, a second-site adaptation occurred in the 5′UAR, leading to
Fig. 5. RNA binding assay. (A) Scheme of 3′UAR-PPMO-mediated competition with 5′UAR/3′UAR duplex formation. Two RNAs, one representing the 5′ terminal 190 nucleotides (5′
RNA) and the other representing the 3′ terminal 111 nucleotides (3′RNA), could form 5′/3′RNA duplex when incubated together. Addition of 3′UAR-PPMO causes a reduction in the
formation of 5′/3′RNA duplex, through binding to the 3′RNA. Sequences for both WT and mutant (MT) 5′RNA and 3′RNA are presented. Mutated nucleotides are indicated in shaded
circles. (B) Competition assays. 32P-labeled 3′RNA probe (lane 1) was converted to a 5′/3′RNA duplex when incubated with cold 5′RNA (lane 2). Indicated amounts of 3′UAR-PPMO
were added to the mixture of 5′RNA and 3′RNA (lanes 3–6 and 9–12). The reactions were then analyzed on a nondenaturing polyacrylamide gel. The effect of 3′UAR-PPMO on 5′/3′
RNA duplex formation was analyzed using WTor MT RNA. The positions of the free probe of 3′RNA, 5′/3′RNAs duplex, and 3′RNA/3′UAR-PPMO complex are indicated on the left side
of the gels; the concentrations of 3′UAR-PPMO are indicated on top of the gel. (C) Quantiﬁcation of WT and MT 5′/3′RNA duplexes with increasing amounts of 3′UAR-PPMO. The
amount of 5′/3′RNA duplex remaining after competition treatment with 3′UAR-PPMO was measured using a PhosphoImager. For each 3′UAR-PPMO concentration, the
value=amount of 5′/3′RNA duplex with PPMO/amount of 5′/3′RNA duplex without PPMO×100. Mean values from three experiments are shown.
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and the mutated 3′UAR (Sel I and Sel III).
A single-nucleotide mutation within the PPMO-binding site confers
resistance to 3′UAR-PPMO
We only sequenced the terminal regions of the viral genomes from
the resistant viruses. Mutations outside the sequenced regions may
contribute to the resistant phenotype. In addition, since we performed
population sequencing (rather than sequencing of plaque-puriﬁed
isolates), quasispecies within the viral population may act together to
confer resistance. To exclude these two possibilities, we engineered
the recovered mutations, both singly and in combination, into an
infectious cDNA clone of WNV. For mutations recovered from Sel I and
Sel III, three mutant WNVs were prepared: A89G, U-74C, and A89G
+U-74C. For the mutation recovered from Sel II, one mutant C-69U
virus was constructed. For all recombinant viruses, we ﬁrst compared
their plaque morphologies with that of the WT virus. As shown in Fig.
4, plaques from mutant viruses U-74C and C-69U were smaller than
those from the WT virus. The smaller plaques of the U-74C and C-69U
viruses correlatedwith theweakened base pairing of the 5′UAR/3′UAR
interaction: a single-nucleotide mismatch in the U-74C mutant virus
(Fig. 4C), and a G/C→G/U change (mutated nucleotide underlined) in
the C-69U mutant virus (Fig. 4E). In contrast, recombinant A89G
and A89G+U-74C viruses developed plaque sizes equivalent to that
of the WT virus (Fig. 4). Furthermore, mutant A89G+U-74C and
C-69U viruses exhibited plaque morphology similar to those derived
from the Sel I and III, and the Sel II viruses, respectively (compare Fig. 4
with Fig. 2A).We next characterized the resistant phenotypes of the recombi-
nant viruses by comparing the growth kinetics in the presence or
absence of 20 μM 3′UAR-PPMO. WT (Fig. 4A) and Sel I viruses (Fig. 4F)
were included as controls. In the absence of PPMO, the mutant viruses
were not grossly incapacitated in replication, as indicated by similar
viral titers derived from the mutant andWT viruses. However, mutant
U-74C virus replicated to a slightly lower titer than the WT virus at
42 h post-infection (p.i.); this small growth disadvantage, due to the
single-nucleotide A/C mismatch between the 5′UAR and the 3′UAR,
could provide a selective pressure for the emergence of the
compensatory A89Gmutation in the 5′UAR after continuous passages,
leading to the restoration of perfect base pairings between the 5′UAR
and the 3′UAR sequences. In the presence of PPMO, viral titers of both
WT and A89G viruses were signiﬁcantly suppressed. In contrast,
recombinant viruses U-74C, A89G+U-74C, and C-69U were not
substantially inhibited by 3′UAR-PPMO. As expected, Sel I virus was
not signiﬁcantly suppressed by the inhibitor (Fig. 4F). These results
demonstrate that a single-nucleotide mutation within the 3′UAR (i.e.,
U-74C or C-69U, leading to a mismatch or a weakened base-pairing
interaction between the 3′UAR and the PPMO) is the determinant for
resistance. In addition, the similarity in viral titer between cells that
were mock-treated or 20 μM 3′UAR-PPMO-treated indicates that the
3′UAR-PPMO did not cause cytotoxicity.
Notably, the originally selected WNVs (P8 of Sel I, Sel II, and Sel III
in Fig. 1E, bottom panel) were less resistant to 3′UAR-PPMO than
were the recombinant viruses (A89G+U-74C and C-69U in Fig. 4).
Since we did not sequence the complete genome of the selected
viruses, it is not possible to conclude that the discrepancy was due to
unidentiﬁed mutations in the Sel I, Sel II, and Sel III viruses.
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nature of the selected viruses.
A single-nucleotide mismatch reduces the ability of 3′UAR-PPMO to
block the RNA/RNA interaction required for WNV genome cyclization
We hypothesized that the mechanism by which the 3′UAR-PPMO
exerts antiviral activity is through interference with the 5′UAR/3′UAR
base-pairing interaction, leading to reduced viral genome cyclization
(Fig. 5A). In resistant viruses, a single-nucleotide change in the 3′UAR
could be expected to result in weakened binding between the 3′UAR
and the 3′UAR-PPMO. To directly test this hypothesis, we performed
RNA binding assays to measure the effect of a single-nucleotide
mismatch on the PPMO-mediated suppression of the RNA/RNA
interaction required for genome cyclization. The assay involves two
RNAs, one representing the 5′ terminal 190 nt (5′RNA; containing 5′UAR
and 5′CS) and the other representing the 3′ terminal 111 nt (3′RNA;
containing 3′CSI and 3′UAR). As shown in Fig. 5B, 32P-labeled 3′RNA
(lane 1) could be converted to an RNA duplex in the presence of
unlabeled 5′RNA (lane 2) on a native polyacrylamide gel. Addition of 3′
UAR-PPMO suppressed the formation of 5′/3′RNA duplex in a dose-
responsive manner (lanes 3–6). Concurrently, a new band, probably
representing 3′RNA/3′UAR-PPMO complex, appeared; however, the
putative complex band was weak and smeared. A similar band pattern
for the 3′RNA/3′UAR-PPMO complex was observed in our previous
study, and was attributed to the positive charge of the peptide
component of the PPMO hindering entrance of the PPMO-RNA complex
into the gel (Zhang et al., 2008). Nevertheless, the results from both
studies conﬁrm that the 3′UAR-PPMO disrupts the 5′/3′RNA duplex.
Next, we prepared a mutant 5′RNA containing the A89G substitu-
tion in the 5′UAR, and a mutant 3′RNA harboring the U-74C change in
the 3′UAR. Mixing of the two mutant RNAs, in which the 3′RNA was
32P-labeled, resulted in a mutant 5′/3′RNA duplex (Fig. 5B, lane 8).
Competition assays showed that, although the 3′UAR-PPMO could
disrupt the mutant 5′/3′RNA duplex (Fig. 5B, lanes 8–12), the
efﬁciency was much lower than for its disruption of the WT RNA
duplex (Fig. 5C). For instance, 10-μM 3′UAR-PPMO competed away
100% of the WT RNA duplex but less than 50% of the mutant RNA
duplex. The results suggest that, due to a single-nucleotide mismatch,
the 3′UAR-PPMO has a reduced ability to block the RNA/RNA
interaction required for genome cyclization in the resistant viruses.
Discussion
A number of approaches have been reported for development of
ﬂavivirus antiviral compounds (Shi, in press). We have been exploring
the possibility of inhibiting ﬂavivirus infections through interference
with cis elements of viral RNA. Results from several groups have
shown that PPMOs designed to interfere with the 5′CS/3′CSI or 5′UAR/
3′UAR base-pairing interactions can inhibit ﬂaviviruses both in cell
culture and in animal models (Deas et al., 2005, 2007; Holden et al.,
2006; Kinney et al., 2005; Stein et al., 2008; Zhang et al., 2008). In this
study, we have selected and characterized WNVs resistant to 3′UAR-
PPMO. Our results suggest thatWNV can develop resistance to 3′UAR-
PPMO through co-selection of 5′UAR and 3′UAR elements that result
in a 3′UAR/3′UAR-PPMO mismatch or a weakened 3′UAR/3′UAR-
PPMO base pairing, while maintaining 5′UAR/3′UAR base pairings.
These results represent the ﬁrst demonstration that a secondary
mutation outside of the PPMO target site can restore the ability of
virus to establish an important RNA/RNA interaction with a region
containing a primary mutation in the PPMO target site.
The successful selection of PPMO-3′UAR resistant viruses allowed
us to identify nucleotide changes responsible for the drug resistance.
Two types of mutations were recovered from the 3′UAR-PPMO-
resistant WNVs (Fig. 2C). Type I mutation was derived from Sel II, and
contained a nucleotide change (C-69U) that allows maintenance ofbase pairing with the 5′UAR. No mutation occurred in the 5′UAR
region. Type II mutations were derived from both Sel I and Sel III, and
contained a change (U-74C) that weakened the base pairing with the
WT 5′UAR. Mutagenesis analysis demonstrated that both types of
mutations contribute to the resistance phenotype (Figs. 4C–E). In
agreement with the genetic results, biochemical binding analysis
showed that, due to the single-nucleotide changes, the 3′UAR-PPMO
had a reduced ability to block the RNA/RNA interaction required for
genome cyclization (Fig. 5). Furthermore, in type II resistant viruses,
one nucleotide in 5′UAR (A89G) was co-selected, leading to a
restoration of perfect base pairings between the 5′UAR and 3′UAR
sequences. The co-evolution of changes in the 5′UAR and 3′UAR
sequences during resistance development provides novel genetic
evidence for the importance of the 5′UAR/3′UAR interaction in
ﬂavivirus replication
The 3′UAR-PPMO-resistant viruses (Sel I and Sel III) contained
mismatch mutations within the PPMO-targeted region. These results
are in agreement with our previous study on a PPMO targeting the
ﬁrst 20 nt of theWNV genomic RNA (5′-end-PPMO) (Deas et al., 2007).
The 5′-end-PPMO-resistant virus accumulated mismatch changes
within the PPMO-targeted region. In contrast, we found that WNV
resistant to a PPMO targeting the 3′CSI (3′CSI-PPMO) accumulated
mutations outside the PPMO-binding site; a single-nucleotide dele-
tion or insertion, located in the 3′ terminal stem–loop of the genomic
RNA, was responsible for the 3′CSI-PPMO resistance (Deas et al.,
2007). Although both 5′CS/3′CSI and 5′UAR/3′UAR interactions
contribute to ﬂavivirus genome cyclization, it is puzzling why
PPMOs targeting the 5′CS/3′CSI (3′CSI-PPMO) and the 5′UAR/3′UAR
(3′UAR-PPMO) interactions produce resistance-determining nucleo-
tide(s) outside and inside the targeted RNA sequences, respectively.
Both the 5′CS/3′CSI and 5′UAR/3′UAR interactions have been shown to
be critical for viral RNA synthesis inWNV (Khromykh et al., 2001; Lo et
al., 2003; Zhang et al., 2008) and DENV (Alvarez et al., 2005a,b, 2008;
You et al., 2001; You and Padmanabhan, 1999; Yu et al., 2008).
However, the two RNA interactions may function through distinct
mechanisms during viral replication, leading to different outcomes in
our resistance studies.
In summary,WNV develops resistance to 3′UAR-PPMO through co-
selection of 5′UAR and 3′UAR sequences that each contains a single-
nucleotide mismatch or a weakened base pairing with the PPMO,
while maintaining the 5′UAR/3′UAR base pairings. The single-
nucleotide change within the 3′UAR reduces the efﬁcacy of 3′UAR-
PPMO to block the RNA/RNA interaction required for genome
cyclization, while the 5′UAR mutation allows the 5′UAR/3′UAR base
pairings to be maintained. More biochemical and genetic studies are
required to illuminate the molecular mechanism of the 5′UAR/3′UAR
interaction in the viral life cycle.
Materials and methods
Viruses and cells
Baby hamster kidney (BHK) cells and African greenmonkey kidney
cells (Vero cells; American Type Culture Collection) were grown in 5%
CO2 at 37 °C with DMEM plus 10% FCS. Conﬂuent cell monolayers and
virus-infected cells were maintained in DMEM plus 2% FCS. WNV was
produced from an infectious cDNA clone pFLWNV by electroporation
of BHK cells with in vitro-transcribed RNA (Shi et al., 2002).
RNA transcription and transfection
Replicon and genome-length RNAs were transcribed from the Xba
I-linearized cDNA plasmids using T7 mMESSAGE mMACHINE kits
(Ambion). The transcription reactions were performed according to
the manufacturer's protocols. For transfection, approximately 5 μg of
RNA was electroporated into 8×106 BHK-21 cells in 0.8-ml ice cold
105B. Zhang et al. / Virology 382 (2008) 98–106phosphate-buffered saline (PBS; pH 7.5) in a 0.4-cm cuvette, with the
GenePulser apparatus (Bio-Rad) using settings of 0.85 kV and 25 μF,
pulsing three times at 3-s intervals. After a 10-min recovery at room
temperature, the transfected cells were diluted in 25 ml of DMEM
containing 10% FCS, and were transferred into a T-150 ﬂask. Viruses in
culture ﬂuids were collected after incubation of the ﬂask for 4 days at
37 °C with 5% CO2. Aliquots of the viruses were stored at −80 °C.
Plaque assay
A series of 1:10 dilutions were made by mixing 15 μl of virus
sample with 135 μl of BA-1 diluent (Hanks M199 salts, 1% bovine
serum albumin, 350 mg/l sodium bicarbonate, 100 U/ml penicillin,
100 mg/l streptomycin, and 1 mg/l amphotericin B in 0.05 mol/l Tris,
pH 7.6). One hundred microliters of each dilution were seeded to
individual wells of 6-well plates containing conﬂuent Vero cells
(6×105 cells per well, plated 3 days in advance). The plates were
incubated at 37 °C with 5% CO2 for 1 h before the ﬁrst layer of agar was
added. A second layer of agar containing neutral red was added after
2 days of incubation at 37 °C with 5% CO2. Plaque morphology and
numbers were recorded after incubation of the plates for a further
12 to 24 h.
Selection of 3′UAR-PPMO-resistant virus
3′UAR-PPMO-resistant WNV was selected by passaging of the wild-
type (WT) virus in Vero cells with increasing concentrations of the 3′
UAR-PPMO (Fig. 1D). Viral titers from each passage were determined by
plaque assay. Three selections for 3′UAR-PPMO-resistant WNV were
independently performed (selections I, II, and III). For each selection,
Vero cellmonolayers in a six-well platewere inoculated at amultiplicity
of infection (MOI) of 0.1 withWTor previously passaged virus, in a total
volume of 1 ml BA-1. After incubation at 37 °C for 1 h, the cell
monolayers were washed three times with BA-1 diluent. Three
milliliters of DMEM with 2% FCS plus 3′UAR-PPMO were added to
each well. The supernatants were harvested at 42 h p.i., and aliquots
were stored at −80 °C. Supernatants from the 20 μM PPMO-selected
viruses were subjected to sequencing analyses (see below).
5′ and 3′ rapid ampliﬁcation of cDNA ends (RACE) sequencing of viral RNA
Viral RNA was extracted from virions in culture medium, using
RNeasy kits (Qiagen). The extraction was performed following the
manufacturer's protocol. Viral RNA sample (5 μl) was treated with 10 U
of tobacco acid pyrophosphatase (TAP) (EPICENTRE Biotechnologies)
in a 10-μl reaction at 37 °C for 1 h. The TAP-treated RNA (2 μl) was used
for ligation with 5 U of T4 RNA ligase (Ambion) in a total volume of
10 μl at 37 °C for 1 h. Ligated RNA sample (5 μl) was subjected to
ampliﬁcation using Onestep RT-PCR kit (Invitrogen) with primer pairs
10501v (5′-AGAAAGTCAGGCCGGGAAGTTC-3′; sense sequence; repre-
senting nucleotides 10501 to 10522; GenBank no. AF404756) and 684c
(5′-TGCTGACTTTGTGCACCAACA-3′; antisense sequence; complemen-
tary to nucleotides 664 to 684). The 1.2-kb RT-PCR product, spanning
the 5′ terminal 684 nucleotides and the 3′ terminal 529 nucleotides of
the WNV genome, was gel-puriﬁed by QIAquick Gel Extraction kit
(Qiagen), and was directly subjected to DNA sequencing.
Plasmid construction
WNV genome-length cDNA clones with 5′UAR and 3′UAR muta-
tions were constructed by use of a modiﬁed pFLWNV (Shi et al., 2002)
and two shuttle vectors. Shuttle vector A, used for mutagenesis of the
5′UAR element, was constructed by engineering the BamH I–Sph I
fragment from the pFLWNV (representing the upstream end of the T7
promoter [used for transcription of the genome-length RNA] to
nucleotide position 3627 of the WNV genome) into vector pACYC177containing a modiﬁed cloning cassette (Zhou et al., 2007). A
QuikChange II XL site-directed mutagenesis Kit (Stratagene) was
used to engineer the 5′UAR mutations into shuttle vector A. The
mutated DNA fragment was then pasted back into the pFLWNV clone
at the BamH I and Cla I (nucleotide position 1089) sites.
Shuttle vector B, used for mutagenesis of the 3′UAR element, was
constructed by engineering the Kpn I–Xba I fragment from the
pFLWNV (representing nucleotides 7762 through the 3′ end of the
WNV genome) into pcDNA3.1. A QuikChange II XL site-directed
mutagenesis kit (Stratagene) was used to engineer the 3′UAR
mutations into the shuttle vector B. The mutated DNA fragment was
pasted back into the pFLWNV clone at the Spe I (nucleotide position
8023) and Xba I sites. All constructs were veriﬁed by DNA sequencing.
Growth kinetics of WT and PPMO-resistant viruses in the presence and
absence of PPMO
Vero cells (9×105 in 1ml DMEMmediumplus 10% FCS) were seeded
in each well of a 12-well plate. After 12 h incubation, the cells were
infected with WNV at an MOI of 0.1 in 100 μl of BA-1 solution. After 1 h
infection, the cell monolayers were washed three times with BA-1
diluent. The infected cells were culturedwith 1ml of DMEMplus 2% FCS
with or without a ﬁnal concentration of 20 μM 3′UAR-PPMO. Culture
ﬂuids were collected at various time points p.i. and stored at −80 °C.
Viral titers were determined using a plaque assay as described above.
Native gel analysis of 5′ and 3′RNA duplex formation
Cold and 32P-labeled RNAs representing the 5′ 190 nt or the 3′ 111
nt of the WNV genomic RNA were prepared for analysis of RNA/RNA
interactions. The RNAs were transcribed from PCR products contain-
ing a T7-promoter sequence followed by the template sequence. For
preparation of RNA probes, α-32P-GTP was internally incorporated
into RNAs during in vitro transcription, using a MEGAscript T7 Kit
(Ambion). After transcription, the template DNA was digested using
DNase I, according to the manufacturer's protocol. The reactions were
passed through two G-25 columns (GE Healthcare) to remove
unincorporated NTPs. The resulting RNA was measured using a
scintillation counter.
For analysis of RNA duplex formation of the 5′ 190-nt and 3′ 111-nt
RNAs, approximately 5 pmol of 3′RNA probe (2.5×104 to 4.5×104
CPM) was mixed with cold 5′RNA in a total volume of 15 μl buffer
containing 50 mM Tris–HCl, pH 8.0, 200 mM NaCl, and 5 mM MgCl2.
For analysis of the effects of antisense PPMOs on formation of the 5′
and 3′ RNA duplex, various concentrations of PPMOs were added
during the reaction assembly. The reactions were then incubated at
room temperature for 30 min and resolved on a native 8%
polyacrylamide gel (15×15 cm2). The amounts of radioactivity were
quantiﬁed by PhosphoImager.
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